Skip to content
BioLab
Back to Labs
BioLab · research library

Literature Workspace

Explore evidence. Connect research.

References, not copies: every entry links to its original source and keeps where its metadata came from. Reading states organise the library; they are not a judgement of scientific quality.

References
21
Collections
4
Sources
3

MVA Hackathon 2026 — BUB1B · 3 references

Published sources behind the validated MVA · BUB1B evidence snapshot. Each reference is cited by at least one evidence record. Open the research case.

Supplementary audit documentation · October 24, 2026 research revision · 15 files at commit bc39224

Computational audit documents of this collection's research case, linked at a fixed commit of the research repository. They are not references of the library, experiments or an official resubmission, and they are not counted above. They are read in the “Robustness and limits” step of the case trail and on the case page.

Research article 2024 Reviewed MVA Hackathon 2026 — BUB1B

Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules

Ignasi Toledano, Fran Supek, Ben Lehner Nature Genetics

Abstract Premature termination codons (PTCs) cause ~10–20% of inherited diseases and are a major mechanism of tumor suppressor gene inactivation in cancer. A general strategy to alleviate the effects of PTCs would be to … abstract via Crossref

Evidence snapshot note: Toledano et al. — genome-scale PTC readthrough. Model: Human HEK293T landing-pad reporters; not endogenous BUB1B. Where: Supplementary Table 3; Extended Data Figure 4 · cited by MVA-RT-002

  • nonsense suppression
  • stop codon readthrough
  • premature stop codon
  • nonsense mutation
Research article 2024 Reviewed MVA Hackathon 2026 — BUB1B

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Meenakshi Hegde, Shoba Navai, Christopher DeRenzo and 34 more Nature Cancer

Evidence snapshot note: Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial. Model: People with progressive HER2-positive sarcoma, including rhabdomyosarcoma.. Where: Abstract; Table 1 and response results / Figure 4 located through indexed primary-article text. · cited by MVA-IMMUNE-011

  • HER2
  • chimeric antigen receptor T cells
  • autologous CAR T-cell therapy
  • advanced sarcoma
Research article 2024 Reviewed MVA Hackathon 2026 — BUB1B

Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction

Corina Amor, Inés Fernández-Maestre, Saria Chowdhury and 16 more Nature Aging

Abstract Senescent cells, which accumulate in organisms over time, contribute to age-related tissue decline. Genetic ablation of senescent cells can ameliorate various age-related pathologies, including metabolic dysfunc… abstract via Crossref

Evidence snapshot note: Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction. Model: Naturally aged C57BL/6 mice and high-fat-diet mice.. Where: Figures 3-5 (clearance, safety assessments and metabolic endpoints); Figures 6-7 (persistence/prevention and high-fat diet). · cited by MVA-IMMUNE-011

  • cellular senescence
  • urokinase-type plasminogen activator receptor
  • uPAR
  • exercise capacity

Researcher sign-in

Sign in with your Stackfire account to save references, build collections and tag the library. Reading is open to everyone.

Add reference

Paste a DOI, PMID, PMCID, NCT number or a URL that carries one. Metadata is fetched from the public sources and shown before anything is saved.

New collection

Edit

KBot · Research guide

Prewritten answers · Evidence linked

KBot

Hello, I am KBot, the BioLab research guide. I can explain the research cases, the Literature Workspace, the Evidence Graph and the analysis tools, and where each one stops. Choose a topic below. These are prewritten explanations, not a live AI consultation.

Research information, not individual medical advice. No messages are sent or saved.